New discovery sheds light on the genetic basis of a rare skeletal disorder

A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder.

Pharmalittle: We’re reading about White House eyeing PBMs, Pfizer CEO’s frustrations, and more

Top of the morning to you, and a fine one it is. Cold winds and overcast skies will not deter us from celebrating another brand

February 29, 2024

Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed

January 5, 2024

Alchem faces fines over price-fixing allegation from the European Commission

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.